BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34287029)

  • 1. Delayed cytokine release syndrome after neoadjuvant nivolumab: a case report and literature review.
    Ciner AT; Hochster HS; August DA; Carpizo DR; Spencer KR
    Immunotherapy; 2021 Sep; 13(13):1071-1078. PubMed ID: 34287029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature.
    Tay SH; Toh MMX; Thian YL; Vellayappan BA; Fairhurst AM; Chan YH; Aminkeng F; Bharwani LD; Huang Y; Mak A; Wong ASC
    Front Immunol; 2022; 13():807050. PubMed ID: 35154124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer.
    Tanaka T; Taoka M; Makimoto G; Ninomiya K; Higo H; Fujii M; Ichihara E; Ohashi K; Hotta K; Tabata M; Maeda Y
    Intern Med; 2024 May; 63(9):1261-1267. PubMed ID: 37722894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nivolumab-Induced Cytokine Release Syndrome: A Case Report and Literature Review.
    Ntwali F; Gilliaux Q; Honoré PM
    Am J Case Rep; 2024 Apr; 25():e941835. PubMed ID: 38625840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of cytokine release syndrome accompanied with COVID-19 infection during treatment with immune checkpoint inhibitors for non-small cell lung cancer.
    Murata D; Azuma K; Tokisawa S; Tokito T; Hoshino T
    Thorac Cancer; 2022 Oct; 13(20):2911-2914. PubMed ID: 36073307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine Release Syndrome Induced by Immune-checkpoint Inhibitor Therapy for Non-small-cell Lung Cancer.
    Yomota M; Mirokuji K; Sakaguchi M; Kitahara Y; Chin F; Setoguchi K; Hosomi Y
    Intern Med; 2021 Nov; 60(21):3459-3462. PubMed ID: 33775995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature.
    Liu LL; Skribek M; Harmenberg U; Gerling M
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36878533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine release syndrome induced by pembrolizumab: A case report.
    Zhang X; Fu Z; Yan C
    Medicine (Baltimore); 2022 Dec; 101(49):e31998. PubMed ID: 36626467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine release syndrome and cancer immunotherapies - historical challenges and promising futures.
    Shah D; Soper B; Shopland L
    Front Immunol; 2023; 14():1190379. PubMed ID: 37304291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of fulminant cytokine release syndrome complicated by dermatomyositis after the combination therapy with immune checkpoint inhibitors.
    Ohira J; Kawamoto M; Sugino Y; Kohara N
    Medicine (Baltimore); 2020 Apr; 99(15):e19741. PubMed ID: 32282733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies.
    Freyer CW; Porter DL
    J Allergy Clin Immunol; 2020 Nov; 146(5):940-948. PubMed ID: 32771558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine release syndrome. Reviewing a new entity in the intensive care unit.
    García Roche A; Díaz Lagares C; Élez E; Ferrer Roca R
    Med Intensiva (Engl Ed); 2019 Nov; 43(8):480-488. PubMed ID: 30922608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study.
    Jamieson L; Forster MD; Zaki K; Mithra S; Alli H; O'Connor A; Patel A; Wong ICK; Chambers P
    BMC Cancer; 2020 Aug; 20(1):743. PubMed ID: 32778064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccination and cancer immunotherapy: should they stick together?
    Brest P; Mograbi B; Hofman P; Milano G
    Br J Cancer; 2022 Jan; 126(1):1-3. PubMed ID: 34799696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non-Small Cell Lung Cancer.
    Mattes MD; Eubank TD; Almubarak M; Wen S; Marano GD; Jacobson GM; Ma PC
    Clin Lung Cancer; 2021 Jul; 22(4):268-273. PubMed ID: 33608212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal and Hepatic Complications of Immunotherapy: Current Management and Future Perspectives.
    Dougan M
    Curr Gastroenterol Rep; 2020 Mar; 22(4):15. PubMed ID: 32185493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Local Cytokine Release Syndrome in an Acute Lymphoblastic Leukemia Patient After Treatment With Chimeric Antigen Receptor T-Cell Therapy: A Possible Model, Literature Review and Perspective.
    Luan C; Zhou J; Wang H; Ma X; Long Z; Cheng X; Chen X; Huang Z; Zhang D; Xia R; Ge J
    Front Immunol; 2021; 12():707191. PubMed ID: 34349766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal cytokine-release syndrome in a patient receiving toripalimab: a case report.
    Zhou Y; Zheng GH; Li N; Liu JJ; Wang XH; Li YF
    Immunotherapy; 2023 Jun; 15(9):641-645. PubMed ID: 37139989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.
    Walle T; Bajaj S; Kraske JA; Rösner T; Cussigh CS; Kälber KA; Müller LJ; Strobel SB; Burghaus J; Kallenberger SM; Stein-Thöringer CK; Jenzer M; Schubert A; Kahle S; Williams A; Hoyler B; Zielske L; Skatula R; Sawall S; Leber MF; Kunes RZ; Krisam J; Fremd C; Schneeweiss A; Krauss J; Apostolidis L; Berger AK; Haag GM; Zschäbitz S; Halama N; Springfeld C; Kirsten R; Hassel JC; Jäger D; ; Ungerechts G
    Nat Cancer; 2022 Sep; 3(9):1039-1051. PubMed ID: 35715501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe cytokine release syndrome induced by immune checkpoint inhibitors in cancer patients - A case report and review of the literature.
    Zhang Y; Wen X; OuYang Y; Hu Y; Fang X; Zhang J; Yuan Y
    Heliyon; 2024 Jan; 10(2):e24380. PubMed ID: 38293388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.